Hester Biosciences Ltd Half Yearly Results

Gross Sales

155.07

145.14

165.96

146.24

158.31

Excise Duty

0

0

0

0

0

Net Sales

155.07

145.14

165.96

146.24

158.31

Other Operating Income

0

0

0

0

0

Other Income

15.24

3.14

4.88

6.82

8.42

Total Income

170.32

148.29

170.84

153.06

166.73

Total Expenditure

120.54

120.9

129.15

120.16

130.73

PBIDT

49.78

27.39

41.69

32.9

36

Interest

4.02

1.81

10.9

9.13

10.64

PBDT

45.76

25.58

30.8

23.77

25.36

Depreciation

8.54

8.47

8.34

7.49

9.68

Minority Interest Before NP

0

0

0

0

0

Tax

4.72

5.77

6.46

5.65

5.07

Deferred Tax

0.88

-1.6

0.13

0.21

-0.15

Reported Profit After Tax

31.63

12.95

15.88

10.42

10.75

Minority Interest After NP

0.74

0

1.34

1.48

0.8

Net Profit after Minority Interest

30.89

12.95

14.54

8.93

9.96

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

30.89

12.95

14.54

8.93

9.96

EPS (Unit Curr.)

37.18

15.23

18.66

10.5

12.64

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

8.51

8.51

8.51

8.51

8.51

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

32.1

18.87

25.12

22.49

22.74

PBDTM(%)

-

-

-

-

-

PATM(%)

20.39

8.92

9.56

7.12

6.79